Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?

Detalles Bibliográficos
Autores principales: Ballabio, E, Armesto, M, Breeze, C E, Manterola, L, Arestin, M, Tramonti, D, Hatton, C S R, Lawrie, C H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432485/
https://www.ncbi.nlm.nih.gov/pubmed/22922378
http://dx.doi.org/10.1038/bcj.2012.31
_version_ 1782242213380489216
author Ballabio, E
Armesto, M
Breeze, C E
Manterola, L
Arestin, M
Tramonti, D
Hatton, C S R
Lawrie, C H
author_facet Ballabio, E
Armesto, M
Breeze, C E
Manterola, L
Arestin, M
Tramonti, D
Hatton, C S R
Lawrie, C H
author_sort Ballabio, E
collection PubMed
description
format Online
Article
Text
id pubmed-3432485
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-34324852012-09-05 Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)? Ballabio, E Armesto, M Breeze, C E Manterola, L Arestin, M Tramonti, D Hatton, C S R Lawrie, C H Blood Cancer J Letter to the Editor Nature Publishing Group 2012-08 2012-08-24 /pmc/articles/PMC3432485/ /pubmed/22922378 http://dx.doi.org/10.1038/bcj.2012.31 Text en Copyright © 2012 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Letter to the Editor
Ballabio, E
Armesto, M
Breeze, C E
Manterola, L
Arestin, M
Tramonti, D
Hatton, C S R
Lawrie, C H
Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
title Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
title_full Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
title_fullStr Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
title_full_unstemmed Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
title_short Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
title_sort bortezomib action in multiple myeloma: microrna-mediated synergy (and mir-27a/cdk5 driven sensitivity)?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432485/
https://www.ncbi.nlm.nih.gov/pubmed/22922378
http://dx.doi.org/10.1038/bcj.2012.31
work_keys_str_mv AT ballabioe bortezomibactioninmultiplemyelomamicrornamediatedsynergyandmir27acdk5drivensensitivity
AT armestom bortezomibactioninmultiplemyelomamicrornamediatedsynergyandmir27acdk5drivensensitivity
AT breezece bortezomibactioninmultiplemyelomamicrornamediatedsynergyandmir27acdk5drivensensitivity
AT manterolal bortezomibactioninmultiplemyelomamicrornamediatedsynergyandmir27acdk5drivensensitivity
AT arestinm bortezomibactioninmultiplemyelomamicrornamediatedsynergyandmir27acdk5drivensensitivity
AT tramontid bortezomibactioninmultiplemyelomamicrornamediatedsynergyandmir27acdk5drivensensitivity
AT hattoncsr bortezomibactioninmultiplemyelomamicrornamediatedsynergyandmir27acdk5drivensensitivity
AT lawriech bortezomibactioninmultiplemyelomamicrornamediatedsynergyandmir27acdk5drivensensitivity

Ejemplares similares